4.5 Article

Mapping ventricular expansion onto cortical gray matter in older adults

Journal

NEUROBIOLOGY OF AGING
Volume 36, Issue -, Pages S32-S41

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.neurobiolaging.2014.03.044

Keywords

Biomarkers; Alzheimer's disease; Mild cognitive impairment; Brain imaging; Magnetic resonance imaging (MRI); Cortical; Gray matter; Thickness; Volume; Surface area; Brain structure; Longitudinal

Funding

  1. National Defense Science and Engineering Graduate (NDSEG) Fellowship from the U.S. Department of Defense [32 CFR 168a]
  2. Air Force Office of Scientific Research
  3. National Institute of Biomedical Imaging and Bioengineering [R01 EB008281, R01 EB008432]
  4. National Institute on Aging
  5. National Institute of Biomedical Imaging and Bioengineering
  6. National Institute of Mental Health
  7. U.S. National Library of Medicine
  8. National Center for Research Resources [AG016570, AG040060, EB01651, MH097268, LM05639, RR019771]
  9. ADNI (National Institutes of Health) [U01 AG024904]
  10. Abbott
  11. Alzheimer's Association
  12. Alzheimer Drug Discovery Foundation
  13. Amorfix Life Sciences Ltd
  14. AstraZeneca
  15. Bayer Healthcare
  16. Bio-Clinica, Inc
  17. Biogen Idec Inc
  18. Bristol-Myers Squibb Foundation
  19. Eisai
  20. Elan Pharmaceuticals Inc
  21. Eli Lilly and Company
  22. F. Hoffmann-La Roche Ltd
  23. Genentech, Inc
  24. GE Healthcare
  25. Innogenetics, N.V.
  26. IXICO Ltd
  27. Janssen Alzheimer Immunotherapy Research & Development, LLC
  28. Johnson & Johnson Pharmaceutical Research & Development LLC
  29. Medpace, Inc
  30. Merck Co, Inc
  31. Meso Scale Diagnostics, LLC
  32. Novartis Pharmaceuticals Corporation
  33. Pfizer
  34. Servier
  35. Synarc Inc
  36. Takeda Pharmaceuticals North America
  37. Canadian Institutes of Health Research
  38. National Institutes of Health from the National Institute of General Medical Sciences [P30 AG010129, K01 AG030514]

Ask authors/readers for more resources

Dynamic changes in the brain's lateral ventricles on magnetic resonance imaging are powerful biomarkers of disease progression in mild cognitive impairment (MCI) and Alzheimer's disease (AD). Ventricular measures can represent accumulation of diffuse brain atrophy with very high effect sizes. Despite having no direct role in cognition, ventricular expansion co-occurs with volumetric loss in gray and white matter structures. To better understand relationships between ventricular and cortical changes over time, we related ventricular expansion to atrophy in cognitively relevant cortical gray matter surfaces, which are more challenging to segment. In ADNI participants, percent change in ventricular volumes at 1-year (N = 677) and 2-year (N = 536) intervals was significantly associated with baseline cortical thickness and volume in the full sample controlling for age, sex, and diagnosis, and in MCI separately. Ventricular expansion in MCI was associated with thinner gray matter in frontal, temporal, and parietal regions affected by AD. Ventricular expansion reflects cortical atrophy in early AD, offering a useful biomarker for clinical trials of interventions to slow AD progression. (C) 2015 Elsevier Inc. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available